You are here: Home » Companies » News
Business Standard

Bharat Biotech's Rotavac 5D receives WHO Prequalification

Bharat Biotech on Monday announced that the World Health Organisation has awarded prequalification to its rotavirus vaccine,Rotavac 5D to prevent rotavirus diarrhea, the company said.

Topics
Bharat Biotech | WHO

Press Trust of India  |  Hyderabad 

Bharat Biotech, Covaxin
Photo: Shutterstock

: on Monday

announced that the World Health Organisation (WHO) has awarded prequalification to its rotavirus vaccine,Rotavac 5D to prevent rotavirus diarrhea, a press release from the company said.

The new variant of Rotavac,Rotavac 5D,is a unique rotavirus vaccine formulation that can be administered without a buffer and Its low dose volume (0.5 mL) facilitates easy vaccine logistics, cold chain management and low biomedical waste disposal post-vaccination, it said.

The vaccine is used for the prevention of rotavirus infection, which is prevalent in infants and young children.

Prequalification enables the procurement of Rotavac 5D by agencies such as UNICEF and PAHO (Pan American Health Organisation) and will fast-track global access to this life saving vaccine.

Suchitra Ella, Joint Managing Director, Bharat Biotech, said,ROTAVAC andRotavac 5Dare projects conceived, innovated and executed in India, in collaboration with Indian and global partners.

"Todays announcement is an important step to further strengthen and fulfill Bharat Biotech's vision to address neglected diseases and prevent infections that continue to affect millions in the developing world," she said.

developed the first generation, rotavirus vaccine, Rotavac under a Public-Private Partnership with the Department of Biotechnology, Government of India and 16 other international partners, making it the largest ever social innovation project for public health.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, August 02 2021. 16:50 IST
RECOMMENDED FOR YOU